Cargando…

Expansion of anti-AFP Th1 and Tc1 responses in hepatocellular carcinoma occur in different stages of disease

BACKGROUND: α-Fetoprotein (AFP) is a tumour-associated antigen in hepatocellular carcinoma (HCC) and is a target for immunotherapy. However, there is little information on the pattern of CD4 (Th1) and CD8 (Tc1) T-cell response to AFP in patients with HCC and their association with the clinical chara...

Descripción completa

Detalles Bibliográficos
Autores principales:	Behboudi, S, Alisa, A, Boswell, S, Anastassiou, J, Pathan, A A, Williams, R
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2010
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2837570/ https://www.ncbi.nlm.nih.gov/pubmed/20087354 http://dx.doi.org/10.1038/sj.bjc.6605526

Ejemplares similares

Loss of KCNQ1 expression in stage II and stage III colon cancer is a strong prognostic factor for disease recurrence
por: den Uil, Sjoerd H, et al.
Publicado: (2016)

SERPINB3 is associated with TGF-β1 and cytoplasmic β-catenin expression in hepatocellular carcinomas with poor prognosis
por: Turato, C, et al.
Publicado: (2014)

Increased sensitivity to TRAIL-induced apoptosis occurs during the adenoma to carcinoma transition of colorectal carcinogenesis
por: Hague, A, et al.
Publicado: (2005)

Epigenetic status of LINE-1 predicts clinical outcome in early-stage rectal cancer
por: Benard, A, et al.
Publicado: (2013)

Prognostic role of FGFR1 amplification in early-stage non-small cell lung cancer
por: Cihoric, N, et al.
Publicado: (2014)

Activation of the MAPK pathway is a common event in uveal melanomas although it rarely occurs through mutation of BRAF or RAS
por: Zuidervaart, W, et al.
Publicado: (2005)

Prognostic value of peritumoral heat-shock factor-1 in patients receiving resection of hepatocellular carcinoma
por: Zhang, J-B, et al.
Publicado: (2013)

Pin1 facilitates NF-κB activation and promotes tumour progression in human hepatocellular carcinoma
por: Shinoda, Kimio, et al.
Publicado: (2015)

miR-9-3p plays a tumour-suppressor role by targeting TAZ (WWTR1) in hepatocellular carcinoma cells
por: Higashi, T, et al.
Publicado: (2015)

Clinical implications of insulin-like growth factor 1 system in early-stage cervical cancer
por: Huang, Y-F, et al.
Publicado: (2008)

REG Iα is a biomarker for predicting response to chemotherapy with S-1 plus cisplatin in patients with unresectable stage IV gastric cancer
por: Sekikawa, A, et al.
Publicado: (2013)

Identification of novel helper epitopes of MAGE-A4 tumour antigen: useful tool for the propagation of Th1 cells
por: Ohkuri, T, et al.
Publicado: (2009)

Mcm2 predicts recurrence hazard in stage Ta/T1 bladder cancer more accurately than CK20, Ki67 and histological grade
por: Burger, M, et al.
Publicado: (2007)

Alpha-1-fucosidase as a prognostic indicator for hepatocellular carcinoma following hepatectomy: a large-scale, long-term study
por: Wang, K, et al.
Publicado: (2014)

MicroRNA-199b-5p attenuates TGF-β1-induced epithelial–mesenchymal transition in hepatocellular carcinoma
por: Zhou, Shao-jun, et al.
Publicado: (2017)

ALDH1 is an independent prognostic factor for patients with stages II–III rectal cancer after receiving radiochemotherapy
por: Deng, Y, et al.
Publicado: (2014)

Hypermethylation of multiple genes as clonal markers in multicentric hepatocellular carcinoma
por: Nomoto, S, et al.
Publicado: (2007)

Treatment of hepatocellular carcinoma with major portal vein thrombosis by combined therapy with subcutaneous interferon-α and intra-arterial 5-fluorouracil; role of type 1 interferon receptor expression
por: Ota, H, et al.
Publicado: (2005)

Expansion of CD133(+) colon cancer cultures retaining stem cell properties to enable cancer stem cell target discovery
por: Fang, D D, et al.
Publicado: (2010)

Comparison of the prognostic value of inflammation-based prognostic scores in patients with hepatocellular carcinoma
por: Kinoshita, A, et al.
Publicado: (2012)

Dissemination of hepatocellular carcinoma is mediated via chemokine receptor CXCR4
por: Schimanski, C C, et al.
Publicado: (2006)

Neutrophils: driving progression and poor prognosis in hepatocellular carcinoma?
por: Margetts, Jane, et al.
Publicado: (2018)

PPARγ agonists inhibit growth and expansion of CD133+ brain tumour stem cells
por: Chearwae, W, et al.
Publicado: (2008)

Relative prognostic value of TNM7 vs TNM6 in staging oesophageal cancer
por: Reid, T D, et al.
Publicado: (2011)

Squalene epoxidase, located on chromosome 8q24.1, is upregulated in 8q+ breast cancer and indicates poor clinical outcome in stage I and II disease
por: Helms, M W, et al.
Publicado: (2008)

Mutations within the tyrosine kinase domain of EGFR gene specifically occur in lung adenocarcinoma patients with a low exposure of tobacco smoking
por: Sugio, K, et al.
Publicado: (2006)

TSPY is a cancer testis antigen expressed in human hepatocellular carcinoma
por: Yin, Y-H, et al.
Publicado: (2005)

Detection of phosphatidylserine-positive exosomes for the diagnosis of early-stage malignancies
por: Sharma, Raghava, et al.
Publicado: (2017)

Common dysregulation of Wnt/Frizzled receptor elements in human hepatocellular carcinoma
por: Bengochea, A, et al.
Publicado: (2008)

Assessment of DNA methylation status in early stages of breast cancer development
por: van Hoesel, A Q, et al.
Publicado: (2013)

Identification of serum CCL15 in hepatocellular carcinoma
por: Li, Y, et al.
Publicado: (2013)

Isoforms of endothelin-converting enzyme-1 (ECE-1) have opposing effects on prostate cancer cell invasion
por: Lambert, L A, et al.
Publicado: (2008)

Tumour antigen expression in hepatocellular carcinoma in a low-endemic western area
por: Sideras, K, et al.
Publicado: (2015)

Checkpoint kinase1 (CHK1) is an important biomarker in breast cancer having a role in chemotherapy response
por: Al-kaabi, M M, et al.
Publicado: (2015)

HIF2α is involved in the expansion of CXCR4-positive cancer stem-like cells in renal cell carcinoma
por: Micucci, Carla, et al.
Publicado: (2015)

Changes in the serum proteome associated with the development of hepatocellular carcinoma in hepatitis C-related cirrhosis
por: Ward, D G, et al.
Publicado: (2006)

microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity
por: Zhang, J, et al.
Publicado: (2010)

Tumour microenvironment of both early- and late-stage colorectal cancer is equally immunosuppressive
por: O'Toole, A, et al.
Publicado: (2014)

Strong expression of ID1 protein is associated with decreased survival, increased expression of ephrin-A1/EPHA2, and reduced thrombospondin-1 in malignant melanoma
por: Straume, O, et al.
Publicado: (2005)

Identification and analysis of tumour-associated antigens in hepatocellular carcinoma
por: Shi, Y-Y, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_g7em7jelbc100gbcgf7s0vhc9s